Beam Therapeutics Stock Forecast - Accumulation Distribution
| BEAM Stock | USD 34.26 3.14 10.09% |
Beam Stock Forecast is based on your current time horizon.
The value of RSI of Beam Therapeutics' stock price is about 61 suggesting that the stock is rather overbought by investors as of now. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Beam, making its price go up or down. Momentum 61
Buy Extended
Oversold | Overbought |
Using Beam Therapeutics hype-based prediction, you can estimate the value of Beam Therapeutics from the perspective of Beam Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Beam Therapeutics after-hype prediction price | USD 34.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Beam Therapeutics to cross-verify your projections. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.Beam Therapeutics Additional Predictive Modules
Most predictive techniques to examine Beam price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Beam using various technical indicators. When you analyze Beam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 124756.0 | 478333.0 |
| Check Beam Therapeutics Volatility | Backtest Beam Therapeutics | Information Ratio |
Beam Therapeutics Trading Date Momentum
| On January 22 2026 Beam Therapeutics was traded for 34.26 at the closing time. The top price for the day was 35.34 and the lowest listed price was 30.82 . The trading volume for the day was 3.7 M. The trading history from January 22, 2026 did not affect price variability. The overall trading delta against the current closing price is 8.38% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Beam Therapeutics to competition |
Other Forecasting Options for Beam Therapeutics
For every potential investor in Beam, whether a beginner or expert, Beam Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Beam Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Beam. Basic forecasting techniques help filter out the noise by identifying Beam Therapeutics' price trends.Beam Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beam Therapeutics stock to make a market-neutral strategy. Peer analysis of Beam Therapeutics could also be used in its relative valuation, which is a method of valuing Beam Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Beam Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Beam Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Beam Therapeutics shares will generate the highest return on investment. By undertsting and applying Beam Therapeutics stock market strength indicators, traders can identify Beam Therapeutics entry and exit signals to maximize returns.
Beam Therapeutics Risk Indicators
The analysis of Beam Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Beam Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting beam stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.42 | |||
| Semi Deviation | 3.2 | |||
| Standard Deviation | 5.03 | |||
| Variance | 25.33 | |||
| Downside Variance | 12.33 | |||
| Semi Variance | 10.21 | |||
| Expected Short fall | (4.29) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Beam Therapeutics
The number of cover stories for Beam Therapeutics depends on current market conditions and Beam Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Beam Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Beam Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Beam Therapeutics Short Properties
Beam Therapeutics' future price predictability will typically decrease when Beam Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Beam Therapeutics often depends not only on the future outlook of the potential Beam Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Beam Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.3 M | |
| Cash And Short Term Investments | 850.7 M |
Check out Historical Fundamental Analysis of Beam Therapeutics to cross-verify your projections. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.